Clinical Trial Update: Advancing Lung Cancer Screening: Artificial Intelligence, Multimodal Imaging and Cutting-Edge Technologies for Early Detection and Characterization [NA]

View source ↗

Summary

An upcoming clinical trial evaluating AI, multimodal imaging, and other technologies for early detection and characterization of lung cancer through screening.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Lung Cancer Screening | NA | Status: NOT_YET_RECRUITING